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Background & purpose: Approximately 40% of hemorrhagic stroke survivors develop hydrocephalus. Hyperbaric
oxygen (HBO) has been shown to be anti-inflammation following experimental stroke; however, its effect upon
post-hemorrhagic hydrocephalus formation is not known. The objective of this study is to investigate whether HBO
therapy can effectively reduce hydrocephalus formation and improve neurobehavioral functions in a rat model of
subarachnoid hemorrhage (SAH).
Method: Thirty-eight male Sprague–Dawley rats (300-320 g) rats survived for 21 days from SAH by endovascular
perforation or sham surgery were used. At 24 hours after SAH, HBO (3 atmospheres absolute) or normobaric
oxygen (NBO) administrated for 1 hour once daily for a total of 7 days. Wire hanging and rotarod testing were
conducted at 14 days after SAH, and cognitive functions were evaluated via the Morris water maze, between day
17 to day 21 after surgery. At day 21, rats were sacrificed and cerebroventricular volumes were measured
histologically.
Results: Hydrocephalus exacerbated neurological deficits after SAH, and HBO multiple treatment tendentially
improved the neurobehavioral functions. Spatial learning and memory deficits were noticed after SAH, and rats
with hydrocephalus showed worse learning and memory abilities and HBO treatment showed a minor
improvement. In the SAH group (room air) 4 rats showed an increased ventricular volume at day 21 after
SAH-induction (n = 10). HBO or NBO therapy did not alter the occurrence of hydrocephalus after SAH, as 4 rats in
each of these groups showed an increased ventricular volume (n = 10 per group).
Conclusion: Multiple HBO therapy does not ameliorate hydrocephalus formation in a rat model of SAH; however,
HBO tendentially improved the neurological functions and spatial learning and memory abilities in rats with
hydrocephalus.
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Hydrocephalus defines an expansion of the cerebroven-
tricular system, which is associated with a decrease in
brain tissue as well as compromised neurological func-
tions. The neurological deficits resulted from hydroceph-
alus range from subtle neurocognitive and gait problems
to severe disability requiring permanent cerebrospinal* Correspondence: johnzhang3910@yahoo.com
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unless otherwise stated.fluid (CSF) diversion. Approximately 40% of hemorrhagic
stroke survivors develop a hydrocephalus [1]. Hydroceph-
alus can be classified into communicating, noncommuni-
cating or obstructive types [2]. Decreased absorption of
CSF at the arachnoid granulations is defined as communi-
cating hydrocephalus and an anatomic obstruction, as
noncommunicating. Subarachnoid hemorrhage (SAH) is a
common cause of chronic communicating hydrocephalus
in clinic, which affects up to 20% of the survivors [3].
Although the cause of chronic hydrocephalus after
SAH is still uncertain, previous studies suggested that
proliferation of arachnoid cells and leptomeningealThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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blood clotting products, may impair CSF flow through
the arachnoid villi, resulting in hydrocephalus [4,5].
Current therapies for hydrocephalus rely on invasive
procedures that are associated with high failure and
complication rates [6]. And so far no medical treatment is
effective in long-term treatment of chronic hydrocephalus.
HBO has been shown to reduce inflammation in many
chronic diseases [7,8] and proved to be neuroprotective
and anti-inflammation following experimental stroke [9];
however, its effect upon post-hemorrhagic hydrocephalus
formation is not known. The objective of this current
study is to investigate whether multiple HBO therapy can
effectively reduce hydrocephalus formation and improve
the neurological functions in a rat model of SAH.
Materials and methods
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
All protocols were approved by the Institutional Animal
Care and Use Committee of Loma Linda University.
Experiment design
This is a retrospective study. A total of 38 adult male
Sprague–Dawley rats (300-320 g, Harlan, Indianapolis,
IN) survived for 21 days from SAH by endovascular
perforation (n = 45) or sham surgery (n = 8) were used
for the study. 24 hours after SAH, rats were randomly
divided into 3 groups: SAH, SAH with HBO treatment
(SAH +HBO), SAH with normobaric oxygen (NBO)
treatment (SAH +NBO). Foot-fault, wire hanging and
rotarod tests were conducted at post-operative day 14,
and cognitive functions were evaluated via the Morris
water maze, between day 17 to day 21 after surgery. At
day 21, rats were sacrificed after measuring the body
weight and cerebroventricular volumes were measured
histologically. In SAH, SAH +HBO and SAH +NBO
groups, animals were divided into SAH without hydro-
cephalus (SAH w/t HyC) and SAH with hydrocephalus
(SAH/HyC) respectively according to the results of cere-
broventricular volume. Data were analyzed in Sham, SAH
w/t HyC, SAH/HyC, SAH/HyC +HBO, SAH/HyC +NBO
groups.
Experimental model of SAH and HBO treatment
The endovascular perforation model of SAH was per-
formed as previously described [10]. Briefly, rats were
anesthetized with 3% isoflurane in 70%/30% medical-air/
oxygen, intubated and kept on artificial ventilation dur-
ing surgery. Body temperature was monitored by a rectal
probe and normothermia was maintained by a heating
lamp. A sharpened 4–0 nylon suture was introduced into
the right internal carotid artery (ICA) until resistance wasfelt (approximately 18 mm from the common carotid
bifurcation). The suture was then advanced until the re-
sistance was overcome to perforate the bifurcation of
the anterior and middle cerebral arteries. The suture
was withdrawn immediately after perforation. In Sham
operated animals the suture was inserted into the right
ICA, however no vessel perforation was performed.
After suture removal the incision was closed, and rats
were individually housed in heated cages until recovery.
24 hours after SAH, rats were pressurized in a research
hyperbaric chamber (1300B; Sechrist) at 3 atmospheres
absolutes (ATA) with 100% oxygen (flow of 22 L/min) for
1 h once daily for consecutive 7 days. Doses of HBO were
selected based on previous studies [11]. SAH rats treated
with NBO were used as a control group.
Neurological scores
At 24 h after SAH, Garcia test was performed by a blinded
investigator as previously described with modifications
[12]. The scores given to each rat at the completion of the
evaluation was the summation of all 6 individual test
scores (spontaneous activity, symmetry in the movement
of four limbs, forepaw outstretching, climbing, body
proprioception, and response to vibrissae touch). The
minimum neurological score (most severe deficit) was
3, and the maximum was 18.
Foot-fault test, wire hanging and rotarod
At day 14 (6 days after the last HBO treatment), foot-
fault test, wire hanging and rotarod were measured by
an investigator who was blinded to the experimental
groups as previously described [13]. In the foot fault test,
the rats were placed on a horizontal grid floor for
2 minutes. The foot fault was defined as when the
rat inaccurately placed a fore- or hindlimb and it fell
through one of the openings in the grid. The num-
ber of foot-faults was recorded and was used for the
statistical analysis.
The wire hanging test procedure was basically the
same as that described by Shabani et al. [14] and is used
to assess the muscle strength and balance. Each rat was
suspended with both forepaws on a horizontal steel wire
80 cm long, diameter 7 mm. The animal was held in a
vertical position when its front paws were placed in
contact with the wire. When the rat grasped the wire, it
was released, and the latency to fall was recorded with a
stopwatch. Rats were randomly tested and each animal
was given three trials with a 30 min inter-trial rest
interval.
Rotarod was performed at day 14 after SAH to test
coordination and balance as previously described [15].
The rotarod consists of a rotating horizontal cylinder
(7 cm diameter) that is divided into 9.5-cm-wide lanes.
When placed into a lane, an animal must continuously
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fall off was detected and recorded by a photobeam cir-
cuit. Two consecutive trials were administered, in which
the cylinder started turning at 5 rpm, and was acceler-
ated by 2 rpm every 5 sec. To control for any potential
learning effect due to previous rotarod exposure, an
additional set of more difficult trials was added in which
the cylinder started turning at 10 rpm, and was acceler-
ated by 2 rpm every 5 sec.Morris water maze
At day 17 to day 21 after SAH, Morris water maze was
performed in a blinded setup as previously described
[15]. In brief, it consists of three trials (cued, spatial, and
probe) done over four consecutive days. All trials lasted
a maximum of 60 sec. The cued trials have a visible plat-
form above the water level where the animals were
allowed to remain on the platform for 10 sec after find-
ing it or being guided to it. The spatial trials have the
platform submerged in the water. Once released, they
were allowed to swim in search of the platform. Here
the time taken to find the platform measured spatial learn-
ing. The probe trial; platform is removed completely and
rats were allowed to swim again in search of the platform
measuring spatial memory.Nissl staining and brain ventricular volume
Rats were fatally anesthetized with isoflurane (≥5%)
followed by cardiovascular perfusion with ice-cold PBS
and 10% formaldehyde. Brains were removed and post-
fixed/cryoprotected in 10% formaldehyde/30% sucrose
for 3 days, embedded in mounting medium and frozen
in liquid nitrogen. For all neuropathological analyses
10 μm thick coronal sections were cut on a cryostat
(Leica Microsystems LM3050S), mounted on poly-L-lysine-
coated slides and Nissl stained. Three Nissl-stained coronal
sections at bregma 0 (+/−250 μm) were randomly chosen
and photographed under light microscopy. Morphometric
analysis of these slides was performed by computer-assisted
(Photoshop CS4, Adobe) hand delineation of the ventri-
cles and the total brain area. The relative ventricle area
was calculated as ventricle area/total brain area, and
took the average of the three slices as the value for each
animal.Figure 1 SAH Rats showed neurological deficits at 24 h and no
difference between groups before treatment. There was a very
significant impairment in neurological functions compared with
Sham group at 24 hours after SAH. There is no significant difference
between SAH w/t HyC, SAH/HyC, SAH/HyC + HBO and SAH/HyC +
NBO groups before treatment. Sham, n = 8; SAH w/t HyC, n = 6;
SAH/HyC, n = 4; SAH/HyC + HBO, n = 4; SAH/HyC + NBO, n = 4.
*p < 0.05 compared with Sham.Statistical analyses
Data were expressed as the mean ± SEM. The analysis of
the data was performed using GraphPad Prism software.
Statistical differences among groups were analyzed by
using one-way analysis of variance followed by the Turkey
method. A value of p < 0.05 was taken as significant.Results
SAH rats showed neurological deficits at 24 h and no
difference between groups before treatment
At 24 hours after SAH, there was a very significant impair-
ments in neurological functions compared with Sham
group (Figure 1, p < 0.05, compared with Sham). There is
no significant difference between SAH w/t HyC, SAH/
HyC, SAH/HyC + HBO or SAH/HyC + NBO groups be-
fore treatment. The results showed our SAH model is
successful and stable.
Multiple HBO treatment neither altered the occurrence of
hydrocephalus nor affected the ventricular volume after
SAH
At 21 days after SAH, 4 rats showed an increased ven-
tricular volume compared with Sham (Figure 2, (5.621 ±
0.704)% vs. (1.844 ± 0.129)%, p < 0.05 compared with
Sham); 6 rats showed no significant difference in ventricu-
lar volume (Figure 2, (2.337 ± 0.223)% vs. (1.844 ± 0.129)%,
p > 0.05 compared with Sham); the occurrence of hydro-
cephalus is 40%. HBO or NBO treatment did not alter the
occurrence of hydrocephalus, as 4 rats (40%) in each of
these groups. Multiple HBO treatment did not affect the
cerebroventricular volumes in the hydrocephalic animals
(Figure 2, (5.181 ± 0.807)% vs. (5.621 ± 0.704)%, p > 0.05
compared with SAH/HyC).
Multiple HBO treatment improved the performance of
foot-fault and rotarod in hydrocephalic animals
At 14 days after SAH, animals showed significant defi-
cits in foot fault in left forelimb than in Sham group
(Figure 3A). Hydrocephalus deteriorated the performance
Figure 2 Multiple HBO treatment neither altered the
occurrence of hydrocephalus nor affected the ventricular
volume after SAH. At 21 days after SAH, 4 rats showed an
increased ventricular volume compared with Sham; 6 rats showed
no significant difference in ventricular volume. HBO or NBO
treatment did not alter the occurrence of hydrocephalus, as 4 rats in
each of these groups. Neither HBO nor NBO treatment affected the
cerebroventricular volumes in the hydrocephalic animals. Sham,
n = 8; SAH w/t HyC, n = 6; SAH/HyC, n = 4; SAH/HyC + HBO, n = 4;
SAH/HyC + NBO, n = 4. *p < 0.05 compared with Sham, #p < 0.05
compared with SAH w/t HyC.
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treatment did not significantly ameliorate the deficits of
foot fault in hydrocephalic animals (Figure 3A, p > 0.05,
compared with SAH/HyC), but showed tendency to im-
prove the performance and removed the significance
between SAH w/t HyC (Figure 3A, p > 0.05, compared
with SAH w/t HyC). After SAH, there is no significant
reduce of muscle strength in hydrocephalic animals
(Figure 3B, p > 0.05, compared with SAH w/t HyC), and
HBO treatment did not increase the time of wire hang-
ing (Figure 3B, p > 0.05, compared with SAH w/t HyC).
In accelerating rotarod, hydrocephalic animals more
easily fell off from the rotarod than non-hydrocephalic
rats (Figure 3C, p < 0.05, compared with SAH w/t HyC),
and HBO treatment showed minor improvement by
eliminating the significance between SAH w/t HyC. NBO
treatment showed no improvements in the performance
foot-fault, wire hanging and rotarod.
There was a significant decrease of body weight at
21 days after SAH (Figure 3D, p < 0.05, compared with
Sham). Hydrocephalus did not affect the body weight
remarkably (Figure 3D, p > 0.05, compared with SAH w/t
HyC), and HBO treatment has no effect on body weight
in long-term (Figure 3D, p > 0.05, compared with SAH/
HyC).Multiple HBO treatment improved spatial learning and
memory abilities in hydrocephalic animals
There were spatial learning and memory deficits at
21 days after SAH. When compared with Sham group,
the animals in SAH w/t HyC group had a significantly
greater distance moved from the target (Figure 4A), need
more time to reach the platform (Figure 4B), showed
less frequency in target quadrants (Figure 4C), spent less
time in the probe quadrants (Figure 4D). Hydrocephalus
exacerbated the performance (Figure 4D, p < 0.05, com-
pared with SAH w/t HyC). Multiple HBO treatment did
not showed significant improvement of memory and
learning abilities when compared with SAH/HyC group
(Figure 4, p > 0.05 compared to SAH/HyC), but removed
the difference between SAH w/t HyC group (Figure 4,
p > 0.05 compared to SAH w/t HyC).
Discussion
In the present study, we observed increased ventricular
volume and deteriorated neurobehavioral after SAH in-
duced by endovascular perforation in rats. The data
showed that 40% of the animals developed hydrocephalus
which was associated with ventricular dilation — the typ-
ical characteristics of chronic communicating hydroceph-
alus. The incidence of hydrocephalus is consistent with its
clinical relevance and our previous study [16]. Repeated
HBO treatment did not ameliorate hydrocephalus forma-
tion but tendentially improve the neurological deficits and
spatial learning and memory abilities. Our data indicates
multiple HBO treatment is beneficial for the recovery of
neurological functions after SAH; however, there is no
improvement in hydrocephalus.
The treatment of hydrocephalus can be divided into
two main groups: surgical and medical treatment [17].
Despite increasing improvements in surgical techniques
and instruments, hydrocephalus remains quite a challenge
for neurosurgery and there is still a high complication rate.
Rapid and effective interventions with medicine are sug-
gested as promising strategies to minimize the occurrence
of hydrocephalus. Inflammatory reaction caused by blood
clotting products after SAH is claimed to be one of the
perpetrators for communicating hydrocephalus [4,18].
HBO has been shown to reduce inflammation in diabetic
foot [8], traumatic brain injury [19], and also in expe-
rimental stroke [9,20]. HBO treatment can suppress in-
flammation by reducing neutrophil-endothelial adhesion
through S-nitrosation [21], reducing the toll-like receptor
signaling pathway [22], increasing heme oxygenase-1 [23]
and inhibiting matrix metalloproteinase-9 [24]. In this
study, HBO seems invalid to prevent the development of
hydrocephalus after SAH. The results suggested that HBO
treatment might not work for anti-inflammation when
begin at 24 hours after SAH. However, multiple HBO
treatment did improve neurobehavioral deficits and spatial
Figure 3 Multiple HBO treatment mildly improved the neurological deficits in hydrocephalic animals. (A) 14 days after SAH, the foot fault
times in left forelimb were significantly higher than that in Sham group. Hydrocephalus deteriorated the performance, and HBO treatment
showed tendency to improve the performance and removed the significance between SAH w/t HyC. (B) After SAH, there is no significant reduce
of muscle strength between hydrocephalic and non-hydrocephalic animals. HBO treatment did not increase the time of wire hanging. (C) In
accelerating rotarod, hydrocephalic animals more easily fell off from the rotarod than non-hydrocephalic rats, and HBO treatment showed minor
improvement by eliminating the significance between SAH w/t HyC. (D) At 21 days after surgery, there is significant difference in body weight
between Sham-operated animals and the SAH-operated animals, but no difference between the SAH-operated with HBO or NBO treatment
groups. Sham, n = 8; SAH w/t HyC, n = 6; SAH/HyC, n = 4; SAH/HyC + HBO, n = 4; SAH/HyC + NBO, n = 4. *p < 0.05 compared with Sham, #p < 0.05
compared with SAH w/t HyC.
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alic animals. The improvements of neurological functions
and cognitive functions may result from the neuroprotec-
tion of HBO and neurogenesis after multiple HBO treat-
ment. HBO treatment has been proved to prevent neuron
apoptosis in experimental stroke [25,26]. And our previ-
ous studies have demonstrated that delayed and multiple
HBO treatment can promote the recovery of neurobeha-
vior through promoting neurogenesis in focal brain ische-
mic rats [11].
In our study, we observed obviously worse neuro-
logical deficits and cognitive functions in hydrocephalic
animals than non-hydrocephalic animals at 21 days after
SAH. We detected the neurological functions at 24 h
after SAH and there is no difference between the SAH
operated animals, which excluded the difference in the
severity of SAH. These findings support the conclusion
that impairments in cognition and motor skills corre-
sponds to ventricular dilation. Previously studies have
shown that hydrocephalus is associated with reductionin cerebral blood flow, impairment in myelin production,
and progressive loss of periventricular axons [27], and
result in progressive motor dysfunction. The impairment
in cognition by hydrocephalus is due to the destruction
of the fimbria/fornix connections, which is critical for
cognitive functions, rather than a direct effect on the
hippocampus [28]. However, wire-hanging was not
substantially impaired in hydrocephalic animals than
non-hydrocephalic animals. And we also have shown
hydrocephalus has no effect on body weight gain after
SAH. The possible explanation is rats learn to accom-
modate to their disability quite well [29,30] and wire-
hanging might not be a sufficient sensitive indicator of
motor and balance. In the rotarad test, we observed a
clear difference in the gait and posture, quantifiable
gait performance between hydrocephalic animals than
non- hydrocephalic animals.
In this study, we didn’t observe beneficial effects of
HBO on hydrocephalus in the SAH animals. There are
some limitations in this study. First, the sample size was
Figure 4 Multiple HBO treatment improved spatial learning and memory abilities in hydrocephalic animals. When compared with Sham
group, the animals in SAH w/t HyC group had a significantly greater distance moved from the target (A), need more time to reach the platform
(B), showed less frequency in target quadrants (C), spent less time in the probe quadrants (D). Hydrocephalus exacerbated the performance.
Multiple HBO treatment did not showed significant improvement of memory and learning abilities when compared with SAH/HyC group, but
removed the difference between SAH w/t HyC group. Sham, n = 8; SAH w/t HyC, n = 6; SAH/HyC, n = 4; SAH/HyC + HBO, n = 4; SAH/HyC + NBO,
n = 4. *p < 0.05 compared with Sham, #p < 0.05 compared with SAH w/t HyC.
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statistical significance. Second, we gave HBO treatment
at 24 hours after SAH, which is a delayed treatment. It
has been reported that HBO is efficient in transient
MCAO within the first 6 hours [31] and future studies
on the therapeutic window of HBO on hydrocephalus in
SAH animals should be investigated. Third, increasing
the number of HBO exposures can promote the effects
of HBO [32]. In this study we administrated HBO once
for each day and multiple-exposure protocols might be
more effective.
In conclusion, in the present study we proved that about
40% animals developed to hydrocephalus and showed be-
havioral and cognitive deficits after SAH. HBO treatment
showed minor improvement in neurobehavioral deficits
and cognitive functions, and did not affect ventricular vol-
ume after SAH. We provide therapeutically relevant data
that HBO had no effects on the development of hydro-
cephalus in SAH model. The improvement in neurological
functions may be resulted from the neurogenesis after
multiple HBO treatment which has been proved in experi-
mental stroke [11]. This work suggests additional studies
should revisit the effective therapy strategies for hydro-
cephalus in clinical trials after SAH.Competing interests
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